• Search
  • Helpdesk
  • Sales contact

ePRO data collection: Decision-making for the adoption of a Bring Your Own Device (BYOD) strategy

17 May 2023

Electronic devices have been systematically provided to participants to report Patient Reported Outcome (PRO) data in clinical trials and electronic Patient Reported Outcomes (ePRO) data collection methods have evolved over time. The current desire to reduce participant burden and drug development costs, combined with improved technology, has led to increasing interest in having study participants use their own devices (‘bring your own device’ or BYOD) to collect PRO data.

However, the uptake of BYOD technologies remains low despite significant interest from industry in their development. The lack of clear regulatory guidance on BYOD approaches has created a vicious circle: clinical teams are not encouraged to pioneer clinical trials submissions using BYOD-collected data, which limits publications on BYOD success stories, meaning that cautious clinical trial teams are not prompted to take the plunge and broadly adopt BYOD options.

What does the industry need to make a step forward and implement BYOD strategies? How can confidence grow so that study participants can benefit from the comfort of using their own device to collect PRO data?

This white paper sets explicit expectations as to what BYOD strategies bring as well as the associated risk, and proposes structured help to support successful BYOD strategy decision-making processes and implementation.

Download the white paper 👇

Kayentis WP post BYOD

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

Mobile in Clinical Trials

16 SEPT 2024 • Philadelphia, USA

DPharm 2024

17-18 SEPT 2024 • Philadelphia, USA

SCDM 2024

29 SEPT - 2 OCT 2024 • Boston, USA


13-16 OCT 2024 • Cologne, Germany


10-13 NOV 2024 • Cologne, Germany

DMB 2024

13 NOV 2024 • Paris, France

SCOPE 2025

FEB 3-6 2025 • Orlando, USA
Booth #931 https://www.scopesummit.com/